Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / cs
-
Total 13F shares
-
17,700
-
Share change
-
+17,700
-
Total reported value
-
$167,973
-
Price per share
-
$9.49
-
Number of holders
-
10
-
Value change
-
+$167,973
-
Number of buys
-
10
Institutional Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) as of Q3 2023
As of 30 Sep 2023,
HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,700 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., UBS Group AG, Federation des caisses Desjardins du Quebec, TORONTO DOMINION BANK, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and ST GERMAIN D J CO INC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.